Technical description: The BVA-100 test utilizes HSA I-131 to make a measure of patient plasma volume utilizing multiple samples for accuracy. The test measures patient total plasma volume and provides a derivative calculation utilizing an input of the patient’s hematocrit to impute a patient’s red cell volume and total blood volume when hematocrit is provided as well as a tracer transudation rate.
Iodine I-131 Iodinated Serum Albumin, Diagnostic, per 5 µCi Volumex™ is a Single-Unit Dose of 25 µCi. Bill A9524 Once & Enter “5” in “Units” Column for Full Reimbursement of the Single-Dose
Plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); multiple samplings for both technical & professional components
Plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); multiple samplings professional interpretation only
Plasma volume, radiopharmaceutical volume-dilution technique (separate procedure); multiple samplings for technical component only
Red cell volume determination (separate procedure); multiple samplings
Red cell volume determination (separate procedure); multiple samplings for professional interpretation only
Red cell volume determination (separate procedure); multiple samplings for technical component only
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance/drug
Disclaimer: Daxor provides this information for your convenience only. It does not constitute legal advice or a recommendation regarding clinical practice. Information provided is gathered from third-party sources and is subject to change without notice due to frequently changing laws, rules, and regulations. The provider has the responsibility to determine medical necessity and to submit appropriate codes and charges for care provided. Daxor makes no guarantee that the use of this information will prevent differences of opinion or disputes with Medicare or other payers as to the correct form of billing or the amount that will be paid to providers of service. Please contact your Medicare contractor, other payers, reimbursement specialists, and/or legal counsel for interpretation of coding, coverage, and payment policies. To access full National Coverage Determination, visit https://www.cms.gov/.
As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.
Call us at 865-425-0555.
Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.